Developments in Neuromodulation Therapies

USD 750

* Required Fields

USD 750


Be the first to review this product

This edition of FT TOE covers technological developments and commercial implications of various neuromodulation therapies that are redefining the standard of care offered by traditional drug-based therapies. The issue covers a snapshot of the global neuromodulation industry, highlighting the intensity of research and commercial prospects for newer clinical applications of these therapies. Detailed analysis of the market and technological drivers and challenges are covered, along with their influence on value of care offered to patients. The issue covers four innovation portfolios within this technology sector, including information and analyst insights on potential business models that could redefine healthcare.

The Future Tech TechVision Opportunity Engine (TOE) captures emerging innovations in research and development, or profile existing technologies which have seen a resurgence in terms of new markets and applications. It usually provides a technology overview, drivers, challenges, research and development, analyst insights and key patent information. In some cases, technology convergence scenarios and future growth opportunities are outlined. It covers innovations and technologies in a variety of industry spaces including manufacturing, sensors, electronics, information and communications technologies, networks, lighting technologies, healthcare, medical devices, materials and coatings, and developments in the energy sector that contribute toward a sustainable and greener world.

The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Neuromodulation therapies, deep brain stimulation, spinal cord stimulation, depression therapies

Table of Contents

Developments in Neuromodulation TherapiesIndustry Snapshot of Neuromodulation TherapiesMost Prescribed Neuromodulation Therapies Target Low Back PainThe Clinical Utilization of Neuromodulators is Extending the Way Patients Undertake TherapiesOEM Efforts to Expand Marketing Channels Are Focused on Widening Clinical ApplicationsDemand for Precise Innervation Triggers Initiatives for Improved Design of Stimulation LeadsEntry of New Participants with Innovative Technologies Affects Pipeline of OEMsKey Technology Developments in Neuromodulation TherapiesCoin-sized Bioelectronic Device for Chronic ConditionsImplantable Neuromodulation Therapy for Inflammatory DiseasesImplantable Neuromodulator for Heart Failure and HypertensionCardiac Contractility Modulation for Chronic Heart FailureIP Landscape of Neuromodulation TherapiesThe United States has Top Rated Jurisdiction for Patents on Neuromodulation TherapiesOptogenetic Therapies for Movement DisordersImplantable Medical Device having a Conducive CoatingAnalyst InsightsDemand for Non-invasive and Collaborative Care Drive Technology-enabled Business ModelsOEMs Need to Transfer Cost Savings across the Value Chain when Evaluating Global Growth StrategiesKey ContactsKey Contacts




Related Research

Release Date : 15-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 01-Dec-17

Region : Global

Related Subscription

• One-2-One Analyst briefing call •
• Access to published and new research deliverables •
• Mid year service review •
• Virtual Analyst briefing •
• GIL conference seats •

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.